Attovia Therapeutics
Presence
Acquisition, funding and merger involving Attovia Therapeutics.
- Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
Executives
View the org chart displaying its 11 main executives
Most searched biographies at Attovia Therapeutics
- Tao Fu, Chief Executive Officer and Director
- Jamie Topper, Chairman of the Board
- Aaron Royston, Director
Popular executive movements at Attovia Therapeutics
- Hubert Chen has joined the company as Chief Medical Officer (posted on March 27 2024).
Create your alert
to follow the executive moves at Attovia Therapeutics.
Biotechnology
Attovia Therapeutics has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
- Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on May 13 2024).
Popular contacts in Biotechnology
News
Press releases by Attovia Therapeutics
Social media about Attovia Therapeutics
- Attovia Therapeutics on Wikipedia, Google News & Yahoo Finance
- Attovia Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Tao Fu 
Call Attovia Therapeutics at +1 510...
